ScholarIQanswers from OpenAlex
Clinique Ambroise Paré
InstitutionResearch output, impact & collaborations
Clinique Ambroise Paré is a institution indexed in ScholarIQ from OpenAlex.
What is known about Clinique Ambroise Paré?
ScholarIQrecord summary
Clinique Ambroise Paré is a research organisation in Neuilly-sur-Seine, FR. OpenAlex records 2,554 works and 82,934 citations for it. 653 researchers list it as their most recent affiliation.
How many works does Clinique Ambroise Paré have?
ScholarIQindexed works
Clinique Ambroise Paré has 2,554 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Clinique Ambroise Paré have?
ScholarIQcitation count
Clinique Ambroise Paré has 82,934 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Clinique Ambroise Paré?
ScholarIQresearcher count
Clinique Ambroise Paré has 653 researchers in the ScholarIQ index.
What is the average h-index at Clinique Ambroise Paré?
ScholarIQavg h-index
Clinique Ambroise Paré has an average h-index of 91 in OpenAlex.
What is the ROR of Clinique Ambroise Paré?
ScholarIQror
The ROR for Clinique Ambroise Paré is on the source record.
What is the OpenAlex record for Clinique Ambroise Paré?
ScholarIQopenalex
The OpenAlex for Clinique Ambroise Paré is on the source record.
Who are the most-cited researchers behind Clinique Ambroise Paré?
ScholarIQtop researchers by citations
What are the most-cited papers on Clinique Ambroise Paré?
ScholarIQmost cited works
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier, Jean Frédéric Colombel, Marc Lémann, Jacques Cosnes, Xavier Hébuterne, Antoine Cortot, Yoram Bouhnik, J P Gendre, Tabassome Simon, Marc Maynadié, Olivier Hermine, Jean Faivre, Fabrice Carrat
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche, Axel Dignaß, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D’Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelić, Johan D. Söderholm, Johanna C. Escher, Sibylle Koletzko, Kaija‐Leena Kolho, Milan Lukáš, Christian Mottet, Herbert Tilg, Séverine Vermeire, F. Carbonnel, A.T. Cole, Gottfried Novacek, Max Reinshagen, Epameinondas V. Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kießlich, Eduard F. Stange, Simon Travis, James O. Lindsay
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
Julián Panés, Yoram Bouhnik, Walter Reinisch, Jaap Stoker, Stuart A. Taylor, Daniel C. Baumgart, Silvio Danese, Steve Halligan, Borut Marinček, Celso Matos, Laurent Peyrin‐Biroulet, Jordi Rimola, Gerhard Rogler, Gert Van Assche, Sandro Ardizzone, Ahmed Ba‐Ssalamah, Maria Antonietta Bali, Davide Bellini, Livia Biancone, Fabiana Castiglione, Robert Ehehalt, Roberto Grassi, Torsten Kucharzik, Francesca Maccioni, Giovanni Maconi, Fernando Magro, J. Martín-Comín, Giovanni Morana, Douglas Pendsé, Shaji Sebastian, Alberto Signore, Damian Tolan, Jeroen A. W. Tielbeek, Dominik Weishaupt, Bart M. Wiarda, Andrea Laghi
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie, Arnaud Bourreille, Julien Branche, Matthieu Allez, Yoram Bouhnik, Jérôme Filippi, Frank Zerbib, Guillaume Savoye, Maria Nachury, Jacques Moreau, Jean‐Charles Delchier, Jacques Cosnes, Elena Ricart, Olivier Dewit, Antonio López–Sanromán, Jean‐Louis Dupas, Franck Carbonnel, Gilles Bommelaer, Benoît Coffin, Xavier Roblin, Gert Van Assche, María Esteve, Martti Färkkilâ, Javier P. Gisbert, Philippe Marteau, Stéphane Nahon, Martine De Vos, Denis Franchimont, Jean-Yves Mary, Jean–Frédéric Colombel, Marc Lémann
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Édouard Louis, Jean‐Yves Mary, Gwénola Vernier-Massouille, Jean–Charles Grimaud, Yoram Bouhnik, David Laharie, Jean‐Louis Dupas, Hélène Pillant, Laurence Picon, M Veyrac, Mathurin Flamant, Guillaume Savoye, Raymond Jian, M. Devos, Raphaël Porcher, Gilles Paintaud, Éric Piver, Jean–Frédéric Colombel, Marc Lémann
How much of the research on Clinique Ambroise Paré is open access?
ScholarIQopen access share
50%OPEN ACCESS